Lipella Pharmaceuticals Common Stock Analysis

Lipella Stock Analysis Notes

About 29.0% of the company outstanding shares are owned by corporate insiders. The book value of Lipella Pharmaceuticals was now reported as 1.79. The company recorded a loss per share of 4.88. Lipella Pharmaceuticals had not issued any dividends in recent years. The entity had 1:8 split on the 8th of November 2024. To find out more about Lipella Pharmaceuticals Common contact the company at 412-901-0315 or learn more at https://www.lipella.com.

Lipella Pharmaceuticals Investment Alerts

Lipella Pharmaceuticals Upcoming and Recent Events

Lipella Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Lipella Stock Institutional Investors

Note, although Lipella Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Lipella Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.57 M.

Lipella Profitablity

Management Efficiency

Lipella Pharmaceuticals has return on total asset (ROA) of (0.9377) % which means that it has lost $0.9377 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7156) %, meaning that it created substantial loss on money invested by shareholders. Lipella Pharmaceuticals' management efficiency ratios could be used to measure how well Lipella Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to drop to -1.36. In addition to that, Return On Capital Employed is likely to grow to -1.41. At this time, Lipella Pharmaceuticals' Net Tangible Assets are very stable compared to the past year. As of the 23rd of November 2024, Other Current Assets is likely to grow to about 174.6 K, while Total Assets are likely to drop about 2.8 M.

Technical Drivers

As of the 23rd of November, Lipella Pharmaceuticals secures the Risk Adjusted Performance of 0.004, standard deviation of 8.27, and Mean Deviation of 5.48. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lipella Pharmaceuticals, as well as the relationship between them.

Lipella Pharmaceuticals Price Movement Analysis

Lipella Pharmaceuticals Insider Trading Activities

Lipella Pharmaceuticals Predictive Daily Indicators

Lipella Pharmaceuticals Corporate Filings

Lipella Pharmaceuticals Forecast Models

Lipella Pharmaceuticals' time-series forecasting models are one of many Lipella Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lipella Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Lipella Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lipella shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lipella Pharmaceuticals. By using and applying Lipella Stock analysis, traders can create a robust methodology for identifying Lipella entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lipella analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Lipella analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Lipella Pharmaceuticals Common stock analysis indicators help investors evaluate how Lipella Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Lipella Pharmaceuticals shares will generate the highest return on investment. By understating and applying Lipella Pharmaceuticals stock analysis, traders can identify Lipella Pharmaceuticals position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipella Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipella Pharmaceuticals. If investors know Lipella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipella Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Lipella Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipella Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipella Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.